ZOTEFOAMS PLC — Director's Dealing 2016

Jun 14, 2016

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 1326B

Zotefoams PLC

14 June 2016

14 June 2016

Zotefoams plc

(the 'Company')

Directors' Share Dealings

The Company was notified on 13 June 2016 that on the same day the following Directors became beneficially interested in the number of ordinary shares of 5 pence in the Company set out against their names in the table below under the Zotefoams Share Incentive Plan (the 'SIP').  The shares were purchased on their behalf by the SIP Trustee (Yorkshire Building Society) at a price of £2.9405 per share.

The SIP is an all-employee trust arrangement approved by HM Revenue and Customs, under which employees are able to buy ordinary shares in the Company, using deductions from salary in each monthly pay period, and receive allocations of matching free ordinary shares ('matching shares').  Dividends received on the shares held in the SIP are used to buy further ordinary shares ('dividend shares') in the Company.

The table below sets out the number of shares purchased and the number of matching shares that were allocated for no consideration.

Director	Number of shares purchased	No. of matching shares allocated
D B Stirling	51	13
G C McGrath	51	13

Following the above-mentioned transactions, Mr Stirling and Mr McGrath are beneficially interested in the following number of shares:

Director	Number of shares¹	Percentage of issued Share Capital
D B Stirling	379,446	0.85
G C McGrath	154	0.00

¹ Includes partnership shares, dividend shares and vested matching shares.

This disclosure has been made for the purposes of DTR 3.1.4.

Enquiries:

James Kindell

Company Secretary

Zotefoams plc

020 8664 1600

About Zotefoams plc:

Zotefoams plc (LSE - ZTF) is a world leader in cellular material technology.  Using a unique manufacturing process with environmentally friendly nitrogen expansion, Zotefoams produces lightweight foams under the family brand names AZOTE® and ZOTEK® in Croydon, UK and Kentucky, USA for diverse markets worldwide through its global sales force.  Zotefoams also owns and licenses patented MuCell® microcellular foam technology from a base in Massachusetts, USA to customers worldwide and sells T-FIT® advanced insulation systems made from its patented ZOTEK® fluoropolymer foams.

AZOTE®, T-FIT® and ZOTEK® are registered trademarks of Zotefoams plc.  MuCell® is a registered trademark of Trexel Inc, licensed exclusively to MuCell Extrusion LLC for use in microcellular foaming of extrusion products.

www.zotefoams.com

This information is provided by RNS

The company news service from the London Stock Exchange

END

DSHEANKLFDEKEEF